See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2017_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 382,535,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,479,000 |
| 3 | remainder_Assets | 27,861,000 |
| 4 | LiabilitiesCurrent | 13,971,000 |
| 5 | LiabilitiesNoncurrent | 301,000 |
| 6 | remainder_Liabilities | 149,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,253,184 |
| 9 | ResearchAndDevelopmentExpense | 59,694,556 |
| 10 | remainder_Expenses | 72,546 |
| 11 | remainder_Revenues | 50,396,849 |
| 12 | remainder_NetIncome | 13,406,701 |
| 13 | remainder_ComprehensiveNetIncome | -29,976 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 413,875,000 |
| 1 | Liabilities | 14,421,000 |
| 2 | Expenses | 80,020,286 |
| 3 | Revenues | 50,396,849 |
| 4 | StockholdersEquity | 399,454,000 |
| 5 | NetIncome | -16,216,736 |
| 6 | ComprehensiveNetIncome | -16,231,724 |
| 7 | BaseVar | 286,074,906 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.99 |
| 9 | EconomicCapitalRatio | 4.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
